학술논문

Selective fetoscopic laser ablation in 100 consecutive pregnancies with severe twin-twin transfusion syndrome
Document Type
Report
Source
Australian and New Zealand Journal of Obstetrics and Gynaecology. Feb, 2009, Vol. 49 Issue 1, p22, 6 p.
Subject
Pregnant women -- Analysis
Pregnant women -- Health aspects
Pregnancy -- Analysis
Pregnancy -- Health aspects
Mortality -- Analysis
Language
English
ISSN
0004-8666
Abstract
To authenticate to the full-text of this article, please visit this link: http://dx.doi.org/10.1111/j.1479-828X.2008.00942.x Byline: Robert B. CINCOTTA (1), Peter H. GRAY (2), Glenn GARDENER (1), Barbara SOONG (1), Fung Yee CHAN (1) Keywords: laser surgery; monochorionic twins; placental anastomoses; twin-twin transfusion syndrome Abstract: Aims: To report the perinatal outcomes of a large series of twin pregnancies with severe twin-twin transfusion syndrome (TTTS) managed with laser ablation surgery in an Australian tertiary perinatal centre and to compare the outcome with other large cohorts. Methods: The outcomes of 100 consecutive pregnancies with severe TTTS managed with selective fetoscopic laser ablation from March 2002 to June 2007 were examined. Survival and neonatal morbidity were analysed. Comparisons were made with the results from other studies of laser surgery with at least 100 pregnancies. Results: There were 100 women with TTTS treated with laser ablation; 34 stage II, 44 stage III and 22 at stage IV. Median gestation at time of laser was 21 weeks (range 18-28) and median gestation at delivery was 31 weeks (range 20-39). Overall perinatal survival rate was 151 of 200 (75.5%). Eighty five per cent had one or more surviving twins. The survival rate for stage IV TTTS was 88.6%, significantly better than for stage II (69.1%) and stage III (73.9%) pregnancies. The perinatal mortality rate for donors (30%) was not significantly different from recipients (19%), but the fetal death rate for donors was significantly greater than that for recipients (P = 0.03). Severe cerebral abnormalities were present in only 2.8% of newborns. The overall survival rate was comparable to other large series. Conclusions: These results for the management of severe TTTS are comparable to the best reported international series. Long-term follow-up is required and more research needs to be undertaken to further improve these results. Author Affiliation: (1)Department of Maternal Fetal Medicine, Mater Mothers' Hospital (2)Department of Neonatology, University of Queensland, Mater Mothers' Hospital, South Brisbane, Queensland, Australia Article History: Received 1 May 2008; accepted 6 August 2008. Article note: Correspondence: Associate Professor Robert Cincotta, Department of Maternal Fetal Medicine, Mater Mothers Hospital, Raymond Terrace, South Brisbane, Qld 4101, Australia. Email: rob@qufw.com.au